Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm
Risk & Insurance - May 12, 2025
GLP-1 agonist drugs are designed to treat type 2 diabetes, but their secondary weight loss effect is driving popularity. The post Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm appeared first on Risk & Insurance. ...
Recommended Articles
Posted: Nov 07, 2025
The latest people news in the industry today. The post Nikole Alcala Promoted to Associate Vice Pres...
Posted: Nov 07, 2025
The latest people news in the industry today. The post John Keogh Named Chairman of North America In...
Posted: Nov 07, 2025
The latest people news in the industry today. The post Alison Erbig Named Executive Vice President a...